Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Jörißen, Hannah ^a   Bektas, Nuran ^b   Dahl, Edgar ^b   Hartmann, Arndt ^c   ten Haaf, Anette ^b   Di Fiore, Stefano ^d   Kiefer, Hans ^e   Thess, Andreas ^e,f   Barth, Stefan ^a,b   Klockenbring, Torsten ^a  

^a FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e M fold Biotech   (Germany)

^f CureVac GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; LIPOSOME; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RAI3; PROTEIN RAI3; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; GPRC5A PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER RECURRENCE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; HYBRIDOMA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; TISSUE MICROARRAY; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST TUMOR; CHEMISTRY; CONFOCAL MICROSCOPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PROCEDURES; GENETICS; METABOLISM; METHODOLOGY;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSOMES; MICROSCOPY, CONFOCAL; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT PROTEINS; RNA, MESSENGER; TISSUE ARRAY ANALYSIS;

EID: 67651250951     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-200     Document Type: Article

References (25)

1. Li S Huang S Peng SB Overexpression of G protein-coupled receptors in cancer cells: Involvement in tumor progression Int J Oncol 2005, 27(5):1329-1339 16211229
2. McCudden CR Hains MD Kimple RJ Siderovski DP Willard FS G-protein signaling: Back to the future Cell Mol Life Sci 2005, 62(5):551-577 10.1007/s00018-004-4462-3 15747061
3. Cheng Y Lotan R Molecular cloning and characterization of a novel retinoic acid-inducible gene that encodes a putative G protein-coupled receptor J Biol Chem 1998, 273(52):35008-35015 10.1074/jbc.273.52.35008 9857033
4. Robbins MJ Michalovich D Hill J Calver AR Medhurst AD Gloger I Sims M Middlemiss DN Pangalos MN et al Molecular cloning and characterization of two novel retinoic acid-inducible orphan G-protein-coupled receptors (GPRC5B and GPRC5C) Genomics 2000, 67(1):8-18 10.1006/geno.2000.6226 10945465
5. Nagahata T Sato T Tomura A Onda M Nishikawa K Emi M Identification of RAI3 as a therapeutic target for breast cancer Endocr Relat Cancer 2005, 12(1):65-73 10.1677/erc.1.00890 15788639
6. Wu Q Ding W Mirza A Van Arsdale T Wei I Bishop WR Basso A McClanahan T Luo L Kirschmeier P et al Integrative genomics revealed RAI3 is a cell growth-promoting gene and a novel P53 transcriptional target J Biol Chem 2005, 280(13):12935-12943 10.1074/jbc.M409901200 15659406
7. Hirano M Zang L Oka T Ito Y Shimada Y Nishimura Y Tanaka T Novel reciprocal regulation of cAMP signaling and apoptosis by orphan G-protein-coupled receptor GPRC5A gene expression Biochemical and biophysical research communications 2006, 351(1):185-191 10.1016/ j.bbrc.2006.10.016
8. Tao Q Fujimoto J Men T Ye X Deng J Lacroix L Clifford JL Mao L Van Pelt CS Lee JJ et al Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene Journal of the National Cancer Institute 2007, 99(22):1668-1682 10.1093/jnci/djm208 18000218
9. Nagahata T Onda M Emi M Nagai H Tsumagari K Fujimoto T Hirano A Sato T Nishikawa K Akiyama F et al Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray Cancer science 2004, 95(3):218-225 10.1111/j.1349-7006.2004.tb02206.x 15016320
10. Kiefer H Vogel R Maier K Bacterial expression of G-protein-coupled receptors: Prediction of expression levels from sequence Receptors Channels 2000, 7(2):109-119 10952088
11. Harris JF Hawley RG Hawley TS Crawford-Sharpe GC Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6 Journal of immunological methods 1992, 148(1-2):199-207 10.1016/ 0022-1759(92)90173-Q 1373425
12. Friguet B Chaffotte AF Djavadi-Ohaniance L Goldberg ME Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay J Immunol Methods 1985, 77(2):305-319 10.1016/0022-1759(85)90044-4 3981007
13. Dahl E Kristiansen G Gottlob K Klaman I Ebner E Hinzmann B Hermann K Pilarsky C Durst M Klinkhammer-Schalke M Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin α2 as a potential novel prognostic marker in breast cancer Clin Cancer Res 2006, 12(13):3950-3960 10.1158/ 1078-0432.CCR-05-2090 16818692
14. Elston CW Ellis IO Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up Histopathology 1991, 19(5):403-410 10.1111/j.1365-2559.1991.tb00229.x 1757079
15. Atlas® cDNA Expression Arrays User Manual http://www.clontech.com/ images/pt/PT3140-1.pdf
16. Remmele W Stegner HE Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Der Pathologe 1987, 8(3):138-140 3303008
17. Lefkowitz RJ Historical review: A brief history and personal retrospective of seven-transmembrane receptors Trends Pharmacol Sci 2004, 25(8):413-422 10.1016/j.tips.2004.06.006 15276710
18. Lagerstrom MC Schioth HB Structural diversity of G protein-coupled receptors and significance for drug discovery Nat Rev Drug Discov 2008, 7(4):339-357 10.1038/nrd2518 18382464
19. Kiefer H Maier K Vogel R Refolding of G-protein-coupled receptors from inclusion bodies produced in Escherichia coli Biochem Soc Trans 1999, 27(6):908-912 10830126
20. Kiefer H In vitro folding of alpha-helical membrane proteins Biochim Biophys Acta 2003, 1610(1):57-62 10.1016/S0005-2736(02)00717-4 12586380
21. Stern DF Heffernan PA Weinberg RA p185, a product of the neu proto-oncogene, is a receptor-like protein associated with tyrosine kinase activity 1986, 6:1729-1740 367701 2878363
22. Nahta R Esteva FJ HER2 therapy: Molecular mechanisms of trastuzumab resistance Breast Cancer Res 2006, 8(6):215 1797036 17096862 10.1186/ bcr1612
23. Brockmann R Beyer A Heinisch J Jr Wilhelm T Posttranscriptional Expression Regulation: What Determines Translation Rates? PLoS Computational Biology 2007, 3(3):e57 1829480 17381238 10.1371/ journal.pcbi.0030057
24. Hartung T Balls M Bardouille C Blanck O Coecke S Gstraunthaler G Lewis D Good Cell Culture Practice. ECVAM Good Cell Culture Practice Task Force Report 1 Altern Lab Anim 2000, 30:407-414
25. Ye X Lotan R Potential misinterpretation of data on differential gene expression in normal and malignant cells in vitro Brief Funct Genomic Proteomic 2008, 7(4):322-6 10.1093/bfgp/eln021 18467351